Use of Vibration Anesthesia Device in Intratympanic Injections
Launched by YUZUNCU YIL UNIVERSITY · Mar 19, 2025
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
ABSTRACT In this study, we aimed to compare the efficacy of four methods including topical lidocaine spray, local anesthetic cream, vibration anesthesia device (VAD), and saline drops (control group) in the reduction of pain after intratympanic steroid injections (ITS's) and to demonstrate the effectiveness of VAD use. The prospective study included 40 patients aged 18-70 years with idiopathic sudden sensorineural hearing loss. Prior to each ITS, all the four methods including local anesthetic cream (EMLA® cream, AstraZeneca PLC), lidocaine spray (Vemcain® Spray), VAD (Blaine®, Blaine Labs,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-70 years with idiopathic sudden sensorineural hearing loss
- Exclusion Criteria:
- • History of otologic surgery,
- • Recent ototoxic drug use,
- • Congenital inner ear malformation,
- • History of chemoradiotherapy due to malignant neoplasia,
- • Presence of acute or chronic otitis media,
- • Age under 18 years, over 70 years
- • History of local anesthesia allergy,
- • Coagulation abnormality,
- • Pregnant and lactating women,
- • Hearing cases with other neurootological diseases
About Yuzuncu Yıl University
Yüzüncü Yıl University is a distinguished institution committed to advancing healthcare through rigorous clinical research. With a strong emphasis on innovation and collaboration, the university actively engages in various clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Its dedicated research teams are equipped with state-of-the-art facilities and a diverse array of expertise, fostering an environment that promotes ethical standards and scientific excellence. Yüzüncü Yıl University is dedicated to contributing to the global medical community by translating research findings into practical applications for improved health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Van, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported